Owens-and-Minor is a medical distribution business based in the US. Owens-and-Minor shares (OMI) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $11.89 – a decrease of 3.1% over the previous week. Owens-and-Minor employs 20,000 staff and has a trailing 12-month revenue of around $10.7 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $11.89 |
|---|---|
| 52-week range | $11.42 - $28.35 |
| 50-day moving average | $14.06 |
| 200-day moving average | $18.25 |
| Wall St. target price | $16.57 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.63 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $12.41 from 2024-11-19
| 1 week (2024-11-14) | 1.14% |
|---|---|
| 1 month (2024-10-21) | -9.68% |
| 3 months (2024-08-21) | -21.60% |
| 6 months (2024-05-21) | -29.77% |
| 1 year (2023-11-21) | -33.32% |
|---|---|
| 2 years (2022-11-21) | -36.16% |
| 3 years (2021-11-19) | 41.8974 |
| 5 years (2019-11-21) | 100.53% |
Valuing Owens-and-Minor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Owens-and-Minor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Owens-and-Minor's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Owens-and-Minor's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Owens-and-Minor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $582.5 million.
The EBITDA is a measure of a Owens-and-Minor's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $10.7 billion |
|---|---|
| Operating margin TTM | 2.01% |
| Gross profit TTM | $1.8 billion |
| Return on assets TTM | 4.02% |
| Return on equity TTM | -5.54% |
| Profit margin | -0.46% |
| Book value | $11.35 |
| Market Capitalization | $946.1 million |
TTM: trailing 12 months
We're not expecting Owens-and-Minor to pay a dividend over the next 12 months.
Owens-and-Minor's shares were split on a 3:2 basis on 31 March 2010 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Owens-and-Minor shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Owens-and-Minor shares which in turn could have impacted Owens-and-Minor's share price.
Over the last 12 months, Owens-and-Minor's shares have ranged in value from as little as $11.42 up to $28.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Owens-and-Minor's is 0.409. This would suggest that Owens-and-Minor's shares are less volatile than average (for this exchange).
Owens & Minor, Inc. , together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.